4 Ways to Ensure the Success of Your COVID-19 Trial

Date & Time:

Wednesday, September 2 at 11 AM EDT (90 min)


Leveraging their experience with clinical development and laboratory services through all development phases, PPD’s experts discuss four common patterns that have emerged from day-to-day involvement with COVID trials that can help ensure the success of your next program.

  •  Specialized, innovative and well-informed protocols
  •  A variety of COVID-19 testing capabilities, technologies and applications
  •  Consideration for rapid global regulatory changes
  •  Partnership with a contract research organization (CRO) to shorten development timelines

Who should attend?

  • Vice Presidents
  • Directors
  • Senior Level Professionals
  • Managers and Department Heads Involved In Clinical Research
  • Vaccine/Pharmaceutical Research and Development Personnel


Carol Olson, MD, PhD

Senior Vice President, Medical and Scientific Strategy, Therapeutic Area Head, Infectious & Respiratory Diseases and Vaccines, PPD

Heather Myler, PhD

Senior Director, Lab Operations, PPD Laboratories Bioanalytical Lab

Katie Matys

Director, Lab Operations, PPD Laboratories Biomarker Lab